Evening – Localized pulmonary fibrosis therapy
Algerian company "Sidral" signed an agreement with the German company "Boehringer Ingelheim" to localize the production of pulmonary fibrosis treatment in Algeria, aiming to strengthen national health sovereignty and develop the pharmaceutical industry. The manufacturing process will take place at the Harrach site in accordance with the latest standards. This agreement is a strategic step toward technology transfer and increasing production capacities in the field of innovative medicines, with plans for additional projects in technological development in the future.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)